Navigation Links
Challenging times for FDA and drug companies equals IT opportunities

Even before the intense scrutiny that started in September when Vioxxs manufacturer removed the drug from the market due to safety concerns, the U.S. Food and Drug Administration and the pharmaceutical industry faced a bumpy road.

One of the biggest challenges has been the pipeline problem, the slowdown instead of the expected acceleration in innovative m......

Full article >>> ing simulation software to improve clinical trial design and predict outcomes.

Better imaging technologies, such as for measuring drug absorption and distribution, may provide powerful insights into the biological effects of pharmaceuticals. But such tools need to be specifically developed and evaluated for drug development. These are but two examples.

Assessing Drug Safety<......

Full article >>> s accepting and investing in bar code technology at a faster rate. Demand for multi-faceted IT systems that improve both productivity and patient safety and well-being will only increase. Facilities already using bar coding will look for enhancements to these systems, and those considering whether and how to adopt bar coding will be evaluating their overall IT needs and options.


Full article >>>
'"/> By Patricia Kaeding 06/13/05

Related biology technology :

1. Sometimes, features can make a company
2. Venture-backed companies drive job creation, even in tough times
3. A disgusting video: U.S. companies sell out Americans
4. Pre-eminent, web-based companies owe success to corporate venturing
5. Visions: IT exec says CIOs must be ready to help companies ramp up trade
6. Patent licensing: For enforcing companies, the rules have changed
7. Madison firm provides $200K in capital to tech companies
8. Gala Biotech among companies sold for $3.3 billion
9. 2006: A mixed blessing for Midwest life science companies
10. Weather information companies launch data product
11. New firm to help companies land federal dollars
Post Your Comments:

(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita ... miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject of ... now. , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, ... launch of their brand, UP4™ Probiotics, into Target stores nationwide. The company, which ... to add Target to its list of well-respected retailers. This list includes such ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
Breaking Biology Technology:
(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
(Date:3/31/2016)... 31, 2016  Genomics firm Nabsys has completed a ... Barrett Bready , M.D., who returned to the company ... technical leadership team, including Chief Technology Officer, John ... Steve Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):